Article
Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Diabetologia - 1 Jan 2012
Rees M G, Wincovitch S, Schultz J, Waterstradt R, Beer N L, Baltrusch S, Collins F S, Gloyn A L
Abstract excerpt
AIMS/HYPOTHESIS: Translation of genetic association signals into molecular mechanisms for diabetes has been slow. The glucokinase regulatory protein (GKRP; gene symbol GCKR) P446L variant, associated with inverse modulation of glucose- and lipid-related traits, has been shown to alter the kinetics of glucokinase (GCK) inhibition. As GCK inhibition is associated with nuclear sequestration, we aimed to determine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
